Wenjing Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wenjing Tang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Rong Yang
Cornell University
5 shared publications - Xiaojing Ma
Robert F. Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14850, USA
3 shared publications - Jiayan Lang
Robert F. Smith School of Chemical & Biomolecular Engineering, Cornell University, Ithaca, NY 14853, USA
2 shared publications - Kwang-Won Park
Robert F. Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14850, USA
2 shared publications Pengyu Chen
Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14850, USA
2 shared publications- Simon Shindler
School of Engineering, Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University , Olin Hall, 113 Ho plaza, Ithaca, New York 14853
2 shared publications
Latest Publications
- 18 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (837) , eadu9186
Neutrophil-mediated delivery of antibiotics across the tympanic membrane for otitis media treatment in a preclinical model
Acute otitis media (AOM) is a leading cause of pediatric antibiotic prescriptions. Systemic antibiotics cause side effects and antibiotic resistance, whereas local delivery of antibiotics (directly to the middle ear) is hindered by an impermeable biological barrier, the tympanic membrane (TM). Here, we developed hydroxylated liposomes that are internalized by neutrophils recruited during AOM to transport encapsulated ciprofloxacin across the intact TM. In mice, complement opsonization of the hydroxylated liposomes increased neutrophil uptake ex vivo and in vivo. In chinchillas with AOM induced by nontypeable Haemophilus influenzae , a hydrogel formulation containing the hydroxylated liposomes applied topically to the TM led to middle ear concentrations of ciprofloxacin that were 36-fold higher than those achieved by liposome-free hydrogels. The pathogens were undetectable within 24 hours, which compares favorably to the current 5- to 10-day treatment using oral antibiotics. The treated TM appeared identical to the pristine ones, and auditory brainstem response thresholds in healthy animals were unchanged by the treatment. Depleting complement proteins using cobra venom factor reduced the transtympanic delivery efficiency and led to a cure rate of 25%, implicating the essential role of complement opsonization in enabling neutrophil hitchhiking. Unlike previous immune cell–based delivery approaches, our method achieves neutrophil hitchhiking through a simple topical application of hydroxylated liposomes, thereby eliminating the need for invasive neutrophil harvesting. It points to a potential low-cost and noninvasive treatment for this prevalent disease, poised to reduce pediatric antibiotic usage.
- 18 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (837) , eadu9186
Neutrophil-mediated delivery of antibiotics across the tympanic membrane for otitis media treatment in a preclinical model
Acute otitis media (AOM) is a leading cause of pediatric antibiotic prescriptions. Systemic antibiotics cause side effects and antibiotic resistance, whereas local delivery of antibiotics (directly to the middle ear) is hindered by an impermeable biological barrier, the tympanic membrane (TM). Here, we developed hydroxylated liposomes that are internalized by neutrophils recruited during AOM to transport encapsulated ciprofloxacin across the intact TM. In mice, complement opsonization of the hydroxylated liposomes increased neutrophil uptake ex vivo and in vivo. In chinchillas with AOM induced by nontypeable Haemophilus influenzae , a hydrogel formulation containing the hydroxylated liposomes applied topically to the TM led to middle ear concentrations of ciprofloxacin that were 36-fold higher than those achieved by liposome-free hydrogels. The pathogens were undetectable within 24 hours, which compares favorably to the current 5- to 10-day treatment using oral antibiotics. The treated TM appeared identical to the pristine ones, and auditory brainstem response thresholds in healthy animals were unchanged by the treatment. Depleting complement proteins using cobra venom factor reduced the transtympanic delivery efficiency and led to a cure rate of 25%, implicating the essential role of complement opsonization in enabling neutrophil hitchhiking. Unlike previous immune cell–based delivery approaches, our method achieves neutrophil hitchhiking through a simple topical application of hydroxylated liposomes, thereby eliminating the need for invasive neutrophil harvesting. It points to a potential low-cost and noninvasive treatment for this prevalent disease, poised to reduce pediatric antibiotic usage.
- Open Access
- 5 February 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (6) , 10518-10529
Nanowire-Mediated Eradication of Polymicrobial Biofilms
Streptococcus pneumoniae (S. pneumoniae) and Nontypeable Hemophiles influenzae (NTHi) are two of the most common pathogens causing otitis media (OM), which is the primary reason for pediatric antibiotic prescriptions. They have been shown to coexist and, in some cases, form biofilms that are resistant to antibiotics, causing recurrent or chronic OM. The current treatment regimen requires a rigorous course of multidose antibiotics over 5–10 days, which is nevertheless found insufficient to eradicate the polymicrobial biofilms. To tackle this challenge, we utilized a nanozyme, i.e., vanadium pentoxide nanowires (V2O5 NWs), to convert a metabolic product (H2O2) of S. pneumoniae into a potent antiseptic (HOBr), thus eradicating polymicrobial biofilms comprising S. pneumoniae and NTHi. Interestingly, when V2O5 NWs were combined with conventional antibiotics (i.e., ciprofloxacin and moxifloxacin), they exhibited synergistic effects against monocultured pathogens, as demonstrated using isobologram analysis. Against S. pneumoniae, regardless of mono- or coculture, additive effects were observed, with the exception of the levofloxacin-ciprofloxacin pair, which resulted in antagonistic effects in cocultured conditions. The strategies developed in this study, therefore, have the potential to tackle polymicrobial OM, biofilm-induced infections and associated antimicrobial resistance while reducing the overall antibiotic exposure incurred by OM.
- 5 February 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (6) , 10518-10529
Open AccessNanowire-Mediated Eradication of Polymicrobial Biofilms
Streptococcus pneumoniae (S. pneumoniae) and Nontypeable Hemophiles influenzae (NTHi) are two of the most common pathogens causing otitis media (OM), which is the primary reason for pediatric antibiotic prescriptions. They have been shown to coexist and, in some cases, form biofilms that are resistant to antibiotics, causing recurrent or chronic OM. The current treatment regimen requires a rigorous course of multidose antibiotics over 5–10 days, which is nevertheless found insufficient to eradicate the polymicrobial biofilms. To tackle this challenge, we utilized a nanozyme, i.e., vanadium pentoxide nanowires (V2O5 NWs), to convert a metabolic product (H2O2) of S. pneumoniae into a potent antiseptic (HOBr), thus eradicating polymicrobial biofilms comprising S. pneumoniae and NTHi. Interestingly, when V2O5 NWs were combined with conventional antibiotics (i.e., ciprofloxacin and moxifloxacin), they exhibited synergistic effects against monocultured pathogens, as demonstrated using isobologram analysis. Against S. pneumoniae, regardless of mono- or coculture, additive effects were observed, with the exception of the levofloxacin-ciprofloxacin pair, which resulted in antagonistic effects in cocultured conditions. The strategies developed in this study, therefore, have the potential to tackle polymicrobial OM, biofilm-induced infections and associated antimicrobial resistance while reducing the overall antibiotic exposure incurred by OM.
- 8 April 2025
- Published by Wiley in Advanced Materials
- Vol. 37 (24) , e2419893
Polymer Microarray with Tailored Morphologies through Condensed Droplet Polymerization for High‐Resolution Optical Imaging Applications
Nature‐inspired functional surfaces with micro‐ and nanoscale features have garnered interest for potential applications in optics, imaging, and sensing. Traditional fabrication methods, such as lithography and self‐assembly, face limitations in versatility, scalability, and morphology control. This study introduces an innovative technology, condensed droplet polymerization (CDP), for fabricating polymeric micro‐ and nano‐dome arrays (PDAs) with readily tunable geometric properties—a challenging feat for conventional methods. The CDP process leverages free‐radical polymerization in condensed monomer droplets, allowing rapid production of PDAs with targeted sizes, radii of curvature, and surface densities by manipulating a key synthesis parameter: the temperature of a filament array that activates initiators. This work systematically unravels its effects on polymerization kinetics, viscoelastic properties of the polymerizing droplets, and geometric characteristics of the PDAs. Utilizing in situ digital microscope, this work reveals the morphological evolution of the PDAs during the process. The resulting PDAs exhibit distinct optical properties, including magnification that enables high‐resolution imaging beyond the diffraction limit of conventional microscopes. This work demonstrates the ability to magnify and focus light, enhancing imaging of subwavelength structures and biological specimens. This work advances the understanding of polymerization mechanisms in nano‐sized reactors (i.e., droplets) and paves the way for developing compact optical imaging and sensing technologies.
- 8 April 2025
- Published by Wiley in Advanced Materials
- Vol. 37 (24) , e2419893
Polymer Microarray with Tailored Morphologies through Condensed Droplet Polymerization for High‐Resolution Optical Imaging Applications
Nature‐inspired functional surfaces with micro‐ and nanoscale features have garnered interest for potential applications in optics, imaging, and sensing. Traditional fabrication methods, such as lithography and self‐assembly, face limitations in versatility, scalability, and morphology control. This study introduces an innovative technology, condensed droplet polymerization (CDP), for fabricating polymeric micro‐ and nano‐dome arrays (PDAs) with readily tunable geometric properties—a challenging feat for conventional methods. The CDP process leverages free‐radical polymerization in condensed monomer droplets, allowing rapid production of PDAs with targeted sizes, radii of curvature, and surface densities by manipulating a key synthesis parameter: the temperature of a filament array that activates initiators. This work systematically unravels its effects on polymerization kinetics, viscoelastic properties of the polymerizing droplets, and geometric characteristics of the PDAs. Utilizing in situ digital microscope, this work reveals the morphological evolution of the PDAs during the process. The resulting PDAs exhibit distinct optical properties, including magnification that enables high‐resolution imaging beyond the diffraction limit of conventional microscopes. This work demonstrates the ability to magnify and focus light, enhancing imaging of subwavelength structures and biological specimens. This work advances the understanding of polymerization mechanisms in nano‐sized reactors (i.e., droplets) and paves the way for developing compact optical imaging and sensing technologies.
- Open Access
- 4 November 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (24) , 6310-6324
Transtympanic delivery of V 2 O 5 nanowires with a tympanic-membrane penetrating peptide
Vanadium pentoxide (V 2 O 5 ) nanowires were modified with trans-tympanic peptides for enhanced trans-tympanic permeability. The as-modified nanowires retain haloperoxidase-like catalytic activities that can be harnessed to combat otitis media pathogens.
- 4 November 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (24) , 6310-6324
Open AccessTranstympanic delivery of V 2 O 5 nanowires with a tympanic-membrane penetrating peptide
Vanadium pentoxide (V 2 O 5 ) nanowires were modified with trans-tympanic peptides for enhanced trans-tympanic permeability. The as-modified nanowires retain haloperoxidase-like catalytic activities that can be harnessed to combat otitis media pathogens.
- 5 January 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 15 (3) , 1014-1023
A cascade nanozyme with antimicrobial effects against nontypeable Haemophilus influenzae
A cascade nanozyme with glucose oxidase and haloperoxidase activities was designed and synthesized, which was shown to generate antiseptic HOBr from a ubiquitous non-ROS, O2. It successfully inhibited growth of a bacterial pathogen and its biofilm.
- 5 January 2023
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 15 (3) , 1014-1023
A cascade nanozyme with antimicrobial effects against nontypeable Haemophilus influenzae
A cascade nanozyme with glucose oxidase and haloperoxidase activities was designed and synthesized, which was shown to generate antiseptic HOBr from a ubiquitous non-ROS, O2. It successfully inhibited growth of a bacterial pathogen and its biofilm.